SG166105A1 - Antifungal composition - Google Patents

Antifungal composition

Info

Publication number
SG166105A1
SG166105A1 SG201007109-0A SG2010071090A SG166105A1 SG 166105 A1 SG166105 A1 SG 166105A1 SG 2010071090 A SG2010071090 A SG 2010071090A SG 166105 A1 SG166105 A1 SG 166105A1
Authority
SG
Singapore
Prior art keywords
antifungal
film
antifungal composition
compositions
agent
Prior art date
Application number
SG201007109-0A
Other languages
English (en)
Inventor
Friedrich Karl Mayer
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of SG166105A1 publication Critical patent/SG166105A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015Drug-containing film-forming compositions, e.g. spray-on
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG201007109-0A 2005-09-29 2006-09-27 Antifungal composition SG166105A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72262505P 2005-09-29 2005-09-29
US72316305P 2005-10-03 2005-10-03

Publications (1)

Publication Number Publication Date
SG166105A1 true SG166105A1 (en) 2010-11-29

Family

ID=37499683

Family Applications (1)

Application Number Title Priority Date Filing Date
SG201007109-0A SG166105A1 (en) 2005-09-29 2006-09-27 Antifungal composition

Country Status (18)

Country Link
US (1) US10525003B2 (pt)
EP (1) EP1931309B1 (pt)
JP (1) JP5174671B2 (pt)
KR (1) KR101333892B1 (pt)
AU (1) AU2006298748B2 (pt)
BR (1) BRPI0616765A2 (pt)
CA (1) CA2623031C (pt)
DK (1) DK1931309T3 (pt)
ES (1) ES2391409T3 (pt)
HK (1) HK1117403A1 (pt)
IL (1) IL189858A (pt)
NO (1) NO339414B1 (pt)
NZ (1) NZ566401A (pt)
PL (1) PL1931309T3 (pt)
PT (1) PT1931309E (pt)
RU (1) RU2417073C2 (pt)
SG (1) SG166105A1 (pt)
WO (1) WO2007039533A2 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101031568B1 (ko) 2008-05-28 2011-05-04 가부시키가이샤 분쵸우 투명 고형상 마카
WO2010093992A1 (en) 2009-02-13 2010-08-19 Topica Pharmaceuticals, Inc Anti-fungal formulation
RU2485955C2 (ru) * 2010-11-17 2013-06-27 Леонид Леонидович Клопотенко Фармацевтическая композиция, содержащая флуконазол, и/или кетоконазол, и/или тербинафин и липосомы для местного применения
FR2976806B1 (fr) * 2011-06-22 2013-06-28 Urgo Lab Composition topique filmogene et son utilisation pour le traitement des mycoses
KR101457789B1 (ko) 2013-02-13 2014-11-03 동아제약 주식회사 상처 치료용 필름형성 약제학적 조성물 및 그의 제조방법
KR101690765B1 (ko) * 2015-04-17 2016-12-28 동아제약 주식회사 항진균성 활성물질을 포함하는 경피 제제
WO2018044621A1 (en) * 2016-08-29 2018-03-08 Schanbacher Carl L Methods and compositions for treating cutaneous fungal infections
US11554108B2 (en) 2016-08-29 2023-01-17 Xeropedix, Inc. Methods and compositions for treating cutaneous fungal infections
US11644458B2 (en) 2016-08-31 2023-05-09 Kabushiki Kaisha Yakult Honsha Method for preparing specimen for analysis or observation of skin
FR3064488B1 (fr) * 2017-03-31 2021-01-01 Urgo Rech Innovation Et Developpement Composition contenant un derive de cellulose, un plastifiant, un solvant volatil et un actif, ses utilisations comme pansement

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3045914A1 (de) * 1980-12-05 1982-07-22 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
JPH0818983B2 (ja) 1987-12-08 1996-02-28 塩野義製薬株式会社 水虫治療剤
US5006346A (en) * 1988-04-28 1991-04-09 Alza Corporation Delivery system
HU223343B1 (hu) 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
US6005001A (en) 1991-05-20 1999-12-21 Novartis Ag (Formerly Sandoz Ag) Pharmaceutical composition
HU219480B (hu) * 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
US5519059A (en) * 1994-08-17 1996-05-21 Sawaya; Assad S. Antifungal formulation
US6060547A (en) * 1995-04-28 2000-05-09 The Proctor & Gamble Company Film forming foundation
AUPO379596A0 (en) * 1996-11-22 1996-12-19 Soltec Research Pty Ltd Percutaneous delivery system
DE69907341T2 (de) * 1998-02-09 2004-01-22 Macrochem Corp., Lexington Antimykotischer nagellack
US6143794A (en) * 1998-04-17 2000-11-07 Bertek Pharmaceuticals, Inc. Topical formulations for the treatment of nail fungal diseases
US6241360B1 (en) * 2000-03-24 2001-06-05 Daniel B. Merrell Lighted writing support and clipboard
JP4899139B2 (ja) * 2000-08-10 2012-03-21 株式会社ポーラファルマ 抗真菌医薬組成物
JP2002068975A (ja) * 2000-08-25 2002-03-08 Pola Chem Ind Inc 抗真菌医薬組成物
JP4803511B2 (ja) * 2000-08-25 2011-10-26 株式会社ポーラファルマ 抗真菌医薬組成物
WO2003105903A1 (ja) * 2002-06-18 2003-12-24 ポーラ化成工業株式会社 抗真菌医薬組成物
AU2002950506A0 (en) * 2002-07-31 2002-09-12 Soltec Research Pty Ltd Percutaneous delivery system
AR045241A1 (es) * 2003-08-12 2005-10-19 Novartis Consumer Health Sa Composicion topica que comprende terbinafina e hidrocortisona
EP1627610A1 (en) * 2004-08-21 2006-02-22 TLT Medical Ltd Drug delivery throug application in nails

Also Published As

Publication number Publication date
EP1931309B1 (en) 2012-09-26
CA2623031A1 (en) 2007-04-12
IL189858A (en) 2015-06-30
IL189858A0 (en) 2008-11-03
RU2417073C2 (ru) 2011-04-27
RU2008116311A (ru) 2009-11-10
AU2006298748A1 (en) 2007-04-12
BRPI0616765A2 (pt) 2011-06-28
WO2007039533A2 (en) 2007-04-12
KR20080049797A (ko) 2008-06-04
JP2009510023A (ja) 2009-03-12
JP5174671B2 (ja) 2013-04-03
NZ566401A (en) 2011-03-31
DK1931309T3 (da) 2013-01-02
EP1931309A2 (en) 2008-06-18
AU2006298748B2 (en) 2010-06-03
ES2391409T3 (es) 2012-11-26
HK1117403A1 (en) 2009-01-16
NO339414B1 (no) 2016-12-12
US20090088434A1 (en) 2009-04-02
NO20082049L (no) 2008-04-29
WO2007039533A3 (en) 2007-08-09
PT1931309E (pt) 2012-11-06
KR101333892B1 (ko) 2013-11-27
PL1931309T3 (pl) 2013-02-28
US10525003B2 (en) 2020-01-07
CA2623031C (en) 2014-05-13

Similar Documents

Publication Publication Date Title
SG166105A1 (en) Antifungal composition
WO2007056073A3 (en) Medical device with a coating comprising an active form and an inactive form of therapeutic agent(s)
BR112014000178A2 (pt) composições tópicas
WO2008036168A3 (en) New small molecule inhibitors of mdm2 and the uses thereof
WO2005072281A3 (en) Methods for coating and impregnating medical devices with antiseptic compositions
WO2007067836A3 (en) Substituted pyrazole compounds useful as soluble epoxide hydrolase inhibitors
MX2007015424A (es) Formulaciones ungueales topicas.
WO2006135854A3 (en) Antiseptic compositions
CY1110153T1 (el) Μυκητοκτονες συνθεσεις
UA86413C2 (ru) Сахарное покрытие и твердая дозированая форма, которая его содержит
WO2007098352A3 (en) Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors
PL1962815T3 (pl) Zastosowanie błonotwórczych polimerów do pielęgnacji włosów z grupy poluretanów i zawierające te polimery preparaty i plastry farmaceutyczne
WO2008020056A3 (de) Aerosolformulierung enthaltend betaagonisten und steroide
NO20081790L (no) Topiske formuleringer
CR10032A (es) Preparación sólida
WO2009082152A3 (en) Glucokinase activators and pharmaceutical compositions containing the same as an active ingredient
WO2007122581A3 (en) Compositions and kits of phenylephrine
BRPI0819719B8 (pt) compostos de inibição de dipeptidil peptidase-iv, métodos de preparação dos mesmos, e preparações farmacêuticas contendo os mesmos como agente ativo
UA101044C2 (ru) Композиция для местного применения для лечения актинического кератоза
MY163503A (en) Aerosol formulations for the inhalation of beta agonists
PT2076119E (pt) Composição solvente incluindo pelo menos dois solventes, e formulação fitossanitária que inclua a composição referida bem como um composto activo
WO2007144521A3 (fr) Composition cosmetique a usage topique comprenant du wasabi
WO2008134013A3 (en) Pharmaceutical excipient complex
TW200738239A (en) Stable solid formulation of sertindole
EA200801139A1 (ru) Композиция для аэрозольной ингаляции